CCRN CROSS COUNTRY HEALTHCARE INC

Nasdaq Services-Help Supply Services DE CIK: 0001141103
AI RATING
SELL
72% Confidence

Investment Thesis

Cross Country Healthcare faces severe operational headwinds with negative operating and net income coupled with a sharp 21.6% YoY revenue decline, indicating structural challenges in the healthcare staffing market. While the strong balance sheet ($105.6M cash, zero long-term debt, 3.29x current ratio) provides financial cushion, the company's deteriorating profitability and low gross margins (19.9%) suggest fundamental business pressures that balance sheet strength alone cannot offset. The positive operating cash flow offers limited reassurance given the sustained unprofitability and revenue erosion trajectory.

Strengths

  • + Fortress balance sheet with $105.6M cash and zero long-term debt reduces financial distress risk
  • + Exceptional liquidity position with 3.29x current ratio provides runway for operational improvements
  • + Positive operating cash flow of $4.8M and positive free cash flow despite accounting losses indicate some operational viability

Risks

  • ! Severe revenue contraction of 21.6% YoY suggests loss of market share or demand collapse in healthcare staffing services
  • ! Persistent operating losses (-4.2M) and negative net income with negative margins indicate structural unprofitability, not cyclical headwinds
  • ! Deteriorating gross margins at 19.9% combined with inability to control costs despite lower revenue volume signal pricing pressure and operational inefficiency

Key Metrics to Watch

Financial Metrics

Revenue
241.1M
Net Income
-4.3M
EPS (Diluted)
$-0.14
Free Cash Flow
3.3M
Total Assets
451.1M
Cash
105.6M

Profitability Ratios

Gross Margin 19.9%
Operating Margin -1.7%
Net Margin -1.8%
ROE -1.4%
ROA -0.9%
FCF Margin 1.4%

Balance Sheet & Liquidity

Current Ratio
3.29x
Quick Ratio
3.29x
Debt/Equity
0.00x
Debt/Assets
30.7%
Interest Coverage
-8.99x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-09T09:55:20.236867 | Data as of: 2026-03-31 | Powered by Claude AI